Feature Story: ‘Cautiously optimistic’ about 2024 HRE sales, lending market

Potential end to Fed hikes could help, as noted during Cushman & Wakefield HRE webinar

By John B. Mugford

Jacob Albers of Cushman & Wakefield kicked off the webcast with an overview of the healthcare and HRE businesses. (HREI photo)

A seasoned debt equity professional involved in the healthcare real estate (HRE) space is “cautiously optimistic” that 2024 will see a better lending environment than the rather “illiquid” year of 2023.

“It’s really tough for banks and all lending institutions to really be able to come to a thesis and gameplan for how to tailor their lending strategy in this current ecosystem,” said Tyler Morss, a director with the U.S. Healthcare Capital Markets team of New York-based Cushman & Wakefield (NYSE: CWK) and who oversees equity, debt and structured finance solutions for clients.

“If we get some stability moving into 2024 and you know, knock on wood, rates continue that march downward, I think it will be a really, a better market than 2023.”

He added

The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE

Existing Users Log In